HR 5219
106th Congress
House
Taxation
AIDS (Disease)
Access to health care
Business income tax
Commerce
Communicable diseases
Congress
Congressional reporting requirements
Developing countries
Drug industry
Finance and Financial Sector
Government Operations and Politics
Health
Human immunodeficiency viruses
Income tax
International Affairs
International cooperation
Malaria
Medical research
Pharmaceutical research
Vaccines for the New Millennium Act of 2000
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Sep 20, 2000
Referred to the House Committee on Ways and Means.
Sep 20, 2000
Introduced in House
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Plain-English summary
Vaccines for the New Millennium Act of 2000 - Amends the Internal Revenue Code to establish a limited vaccine research credit and a limited lifesaving vaccine sales credit.
What's happening now
Referred to the House Committee on Ways and Means.
Bill text
1 version
- Introduced in House Formatted Text PDF
Committees of jurisdiction
1
Cosponsors
1
Cite this page
U.S. Congress. (2026). H.R. 5219: Vaccines for the New Millennium Act of 2000. 106th Congress. Open America. https://openamerica.io/bill/106-HR-5219/
"H.R. 5219: Vaccines for the New Millennium Act of 2000." 106th Congress, 2026, Open America, https://openamerica.io/bill/106-HR-5219/.
H.R. 5219, 106th Cong. (2026), https://openamerica.io/bill/106-HR-5219/.
[H.R. 5219: Vaccines for the New Millennium Act of 2000](https://openamerica.io/bill/106-HR-5219/)